Correction to: Scientific Reports https://doi.org/10.1038/s41598-017-05709-y, published online 13 July 2017
The original version of this Article contained a typographical error in the spelling of the author M. Diana Neely, which was incorrectly given as Diana M. Neely. This has now been corrected in the PDF and HTML versions of the Article as well as the Supplementary Information that now accompanies the Article.
Author information
Authors and Affiliations
Corresponding author
Additional information
The original article can be found online at https://doi.org/10.1038/s41598-017-05709-y.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Di Pardo, A., Amico, E., Basit, A. et al. Author Correction: Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington’s disease. Sci Rep 8, 8266 (2018). https://doi.org/10.1038/s41598-018-23083-1
Published:
DOI: https://doi.org/10.1038/s41598-018-23083-1
